REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that it has initiated its US based Phase 1b clinical study to evaluate the potential of Gemini as a ...

Eyenovia, Inc. (NASDAQ: EYEN) ("Eyenovia" or the "Company"), an ophthalmic technology company focused on completing development of its proprietary Optejet ...

(NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company focused on completing development of its proprietary Optejet topical ophthalmic medication dispensing platform, today ...

The company has already cut its workforce, seen a leadership change and agreed to be acquired. Here's what's next.

Enveric Biosciences Inc. (NASDAQ:ENVB), a pharmaceutical preparations company with a market capitalization of $3.43 million, ...

Splitting a stock doesn’t change a good company into a bad one or vice versa. The price might go up a bit after the split, ...

KOLOA, Hawaii — Surgeons must devise and implement calculated treatment algorithms when performing ... or loose stem with good surrounding bone stock quality is fixable. He added that hip ...

According to InvestingPro data, the stock has shown significant price volatility ... a clinical-stage candidate for the treatment of Epidermolysis Bullosa, to Innovator21 LLC for $8.5 million.

Sodium permanganate has been added to the water treatment strategy to effectively reduce both iron and manganese levels. “The completed installation of the sodium permanganate feed system is an ...

Emi-Le was generally well tolerated, with no Grade 4 or 5 treatment-related adverse events ... Price Action: MRSN stock is down 36.6% at $0.8245 at last check Friday.

Share price of Shriram Finance Ltd. declined by nearly 2% on Thursday, as investors await the company’s upcoming stock split. The ex-date for the 1:5 sub-division of equity shares is set for Jan. 10, ...